UPDATE 1-FDA declines to approve Intellipharma's opioid painkiller [Reuters]
INTELLIPHARMACEUTICS (IPCI)
Last intellipharmaceutics earnings: 10/15 05:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.intellipharmaceutics.com
Company Research
Source: Reuters
UPDATE 1-FDA declines to approve Intellipharma's opioid painkiller | Reuters Reuters Staff 3 Min Read (Adds details on FDA decision, background on opioid abuse crisis) Sept 25(Reuters) - Intellipharmaceutics International Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve its long-acting opioid painkiller in its current form, backing its independent advisory panel that had raised concerns over the drug’s abuse-deterrence capabilities. The decision comes at a time when the United States is battling with the opioid abuse crisis, which claimed more than 33,000 people in 2015, according to the Centers for Disease Control and Prevention. The FDA asked Intellipharma to complete additional studies to assess the abuse-deterrent properties of the drug when used via oral and nasal methods, the company said. Toronto-based Intellipharma’s drug, Oxycodone ER, designed as a unique abuse-deterrent version of Purdue Pharma’s oft-abused blockbuster OxyContin, contains a
Show less
Read more
Impact Snapshot
Event Time:
IPCI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPCI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPCI alerts
High impacting INTELLIPHARMACEUTICS news events
Weekly update
A roundup of the hottest topics